Sail Biomedicines
Sail Biomedicines is a biopharmaceutical company operating at the frontier of programmable medicines. They leverage a proprietary bioplatform that harnesses evolution and AI to generate life-changing medicines. Their core technology includes Endless RNA™ (eRNA), a circular RNA format designed for prolonged protein expression, and programmable nanoparticles utilizing a broad range of natural chemistries for enhanced deployment and targeted delivery. Sail integrates these components with proprietary generative AI to design RNA medicines for a range of diseases including autoimmune, metabolic, infectious, and rare diseases. The company was formed in October 2023, combining over eight years of data and platform-building experience from the Flagship Pioneering ecosystem. They aim to achieve unprecedented performance in RNA medicine development.
Sail Biomedicines
Sail Biomedicines is a biopharmaceutical company operating at the frontier of programmable medicines. They leverage a proprietary bioplatform that harnesses evolution and AI to generate life-changing medicines. Their core technology includes Endless RNA™ (eRNA), a circular RNA format designed for prolonged protein expression, and programmable nanoparticles utilizing a broad range of natural chemistries for enhanced deployment and targeted delivery. Sail integrates these components with proprietary generative AI to design RNA medicines for a range of diseases including autoimmune, metabolic, infectious, and rare diseases. The company was formed in October 2023, combining over eight years of data and platform-building experience from the Flagship Pioneering ecosystem. They aim to achieve unprecedented performance in RNA medicine development.
